Pamela Esposito, Director: Kymera Therapeutics KYMR Planned sale · Filed 25/12/17

Trade details

Type: Planned sale notice
Stock: Kymera Therapeutics KYMR
Person: Pamela EspositoDirector
Planned sale date: 25/12/17
Filed: 25/12/17

$2.3M to be sold

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/17~01/16

Pamela Esposito's recent trades

Pamela EspositoDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$95.9K
1,200 sh
$95.9K
Filed 03/20
Traded 03/20
Pamela EspositoDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$54.4K
700 sh
$54.4K
Filed 03/20
Traded 03/20
Pamela EspositoDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$47.5K
600 sh
$47.5K
Filed 03/20
Traded 03/20
Pamela EspositoDirector
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$198.9K
2,500 sh
$198.9K
Filed 03/20
Traded 03/20
Pamela EspositoDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$165.4K
1,900 sh
$165.4K
Filed 02/20
Traded 02/20

Pamela Esposito, Director — plans to sell 27,563 sh of Kymera Therapeutics KYMR · $2.3M · around 12/17 · 10b5-1 plan | Whalegun